Lg Chem
Clinical trials sponsored by Lg Chem, explained in plain language.
-
New combo pill may help diabetes patients control blood sugar
Disease control CompletedThis completed observational study looked at over 2,000 adults with type 2 diabetes who were already taking metformin plus another diabetes drug. Researchers wanted to see if adding a new combination pill called Zemidapa (which contains two diabetes medicines) could improve blood…
Sponsor: LG Chem • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New gout drug shows promise in lowering uric acid levels
Disease control CompletedThis study tested a new medicine called LC350189 in 156 adults with gout and high uric acid. The goal was to see if different doses could safely lower uric acid below target levels over 12 weeks. Participants took the drug or a placebo, and researchers measured uric acid in the b…
Phase: PHASE2 • Sponsor: LG Chem • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New gout pill shows promise in lowering uric acid levels
Disease control CompletedThis study tested a new medicine called tigulixostat in 354 adults with gout and high uric acid. Participants took one of three doses or a placebo for 6 months. The main goal was to see if the drug could keep uric acid below a target level. The trial is complete and results will …
Phase: PHASE3 • Sponsor: LG Chem • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
One pill to replace three? diabetes combo drug tested
Knowledge-focused CompletedThis study tested whether a single pill containing three diabetes medicines (gemigliptin, dapagliflozin, and metformin) works the same in the body as taking them separately. Fifty healthy adults took either the combo pill or the separate drugs after a meal, and researchers measur…
Phase: PHASE1 • Sponsor: LG Chem • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC